We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Frontdoor
FTDR
$5.02B
| $26.8M | 0.18% |
537,619
+157,823
| +42% | +$8.32M |
|
|
CVSA
152
Covista Inc
CVSA
$3.94B
| $26.3M | 0.18% |
738,051
+527,681
| +251% | +$19.8M |
|
|
MRO
153
DELISTED
Marathon Oil Corporation
MRO
| $26.3M | 0.18% |
1,930,686
-579,887
| -23% | -$7.01M |
|
|
KYNB
154
Kyntra Bio
KYNB
$28.5M
| $26M | 0.18% |
39,095
+37,416
| +2,228% | +$21.6M |
|
|
WCC
155
WESCO International
WCC
$16.2B
| $26M | 0.18% |
252,459
+840
| +0.3% | +$83.5K |
|
|
BLUE
156
DELISTED
bluebird bio
BLUE
| $25.9M | 0.18% |
62,561
+4,148
| +7% | +$1.64M |
|
|
LSXMA
157
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $25.9M | 0.18% |
757,179
-6,643
| -0.9% | -$218K |
|
158
Gray Television
GTN
$407M
| $25.9M | 0.18% |
1,106,798
+690,253
| +166% | +$15M |
|
159
Spectrum Brands
SPB
$2.04B
| $25.9M | 0.18% |
304,142
-65,792
| -18% | -$5.8M |
|
160
Delek US
DK
$3.87B
| $25.9M | 0.18% |
1,195,980
+1,162,797
| +3,504% | +$26.3M |
|
161
TriNet
TNET
$2.84B
| $24.9M | 0.17% |
343,820
-41,527
| -11% | -$3.22M |
|
162
Lear
LEA
$7.19B
| $24.8M | 0.17% |
141,629
+62,421
| +79% | +$11.5M |
|
163
Antero Resources
AR
$10.9B
| $24.7M | 0.17% |
+1,643,210
| New | +$19.3M |
|
164
Extreme Networks
EXTR
$3.86B
| $24.2M | 0.16% |
2,165,748
+80,437
| +4% | +$854K |
|
165
Primoris Services
PRIM
$4.69B
| $23.9M | 0.16% |
812,256
+302,578
| +59% | +$9.76M |
|
166
AXIS Capital
AXS
$8.59B
| $23.7M | 0.16% |
484,178
-35,110
| -7% | -$1.86M |
|
|
167
Qualcomm
QCOM
$176B
| $23.3M | 0.16% |
163,107
-727,191
| -82% | -$98.3M |
|
168
GoPro
GPRO
$116M
| $23.2M | 0.16% |
1,991,350
-1,080,596
| -35% | -$12.2M |
|
169
Expeditors International
EXPD
$22.9B
| $22.9M | 0.16% |
180,794
-328,161
| -64% | -$38.7M |
|
170
Allegiant Air
ALGT
$2.64B
| $22.5M | 0.15% |
116,207
+86,851
| +296% | +$19.5M |
|
|
INFN
171
DELISTED
Infinera Corporation Common Stock
INFN
| $22.2M | 0.15% |
2,180,488
-282,447
| -11% | -$2.74M |
|
172
Ingredion
INGR
$6.38B
| $22.2M | 0.15% |
245,408
+6,985
| +3% | +$652K |
|
173
Pilgrim's Pride
PPC
$6.82B
| $22.1M | 0.15% |
996,555
+25,668
| +3% | +$611K |
|
|
HAPN
174
Happen Inc
HAPN
$2.08B
| $22.1M | 0.15% |
1,218,679
+212,077
| +21% | +$3.3M |
|
175
CoreCivic
CXW
$3.1B
| $22.1M | 0.15% |
2,108,582
+131,935
| +7% | +$1.18M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.